Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 November 2023 | Story Valentino Ndaba | Photo SUPPLIED
UFS KovsieCare GBV Social Media
The UFS is joining forces with the international community during the annual 16 Days of Activism against Gender-Based Violence.

As the world will soon commemorate the 16 Days of Activism against Gender-Based Violence (GBV) campaign, the University of the Free State (UFS) joins the fight against this pervasive issue. Dedicated to eradicating GBV and fostering a safe environment, the institution has pledged an unwavering commitment to a zero-tolerance stance against all forms of GBV.

The 16 Days of Activism against Gender-Based Violence is an annual global initiative that starts on 25 November 2023 – International Day for the Elimination of Violence against Women – and concludes on 10 December 2023 – Human Rights Day. The theme for this year, ‘Accelerating actions to end gender-based violence and femicide: leaving no one behind’, emphasises the need for a comprehensive, inclusive effort to combat GBV. 

Legislation addressing GBV

Gender-based violence, rooted in the systemic imbalance of power and authority, manifests in multifaceted forms that encompass emotional, physical, financial, and sexual abuse, among others. Recognising the gravity of this issue, parliament has enacted laws, including the Domestic Violence Act of 1998 and the Children's Act of 2005, striving to safeguard individuals from such atrocities and championing fundamental human rights.

The UFS, aligned with parliament's vision and encapsulating its own Vision 130 within the 2023-2028 Strategic Plan, remains steadfast in its dedication to fostering a culture of accountability, care, and social justice within its staff and student community. 

The significance of activism

Dr Lentsu Nchabeleng, Deputy Director in the Gender Equality and Anti-Discrimination Office (GEADO), emphasised the pivotal role of the 16 Days of Activism in societal progress. “Advocacy plays an important role in prevention by promoting education and awareness. Advocacy challenges harmful societal norms and stereotypes that contribute to gender-based violence and can help foster a culture of equality and respect," she stated.

Useful resources

The UFS has provided resources for the staff and student community, including frequently asked questions (FAQs) about GBV and sexual offences, aiming to clarify these important matters. Help and reporting avenues for GBV and sexual misconduct are available on the Bloemfontein and South campuses, with similar support available on the Qwaqwa Campus, underscoring the university's dedication to a safe and supportive environment for all. 

Click to download the resource documents:

Important contacts 

The university has also implemented support systems, including dedicated 24-hour toll-free helplines for reporting GBV and sexual offenses, underscoring its commitment to addressing this epidemic.

  • GEADO toll-free: 0800 204 682
  • UFS Student Careline toll-free: 0800 00 6363

 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept